Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
The PRIME trial: An investigator-initiated, multicentre, phase II study of the poly(ADP-ribose) polymerase inhibitor olaparib in isocitrate dehydrogenase (IDH)-mutated relapsed/refractory acute myeloid leukaemia and myelodysplastic syndromes.
Journal: British journal of haematology
Published: July 02, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.
Journal: Blood cancer journal
Published: March 13, 2026
Myelodysplastic syndrome with concomitant SF3B1 mutation and deletion of chromosome 5 long arm: outcomes and response to treatment.
Journal: Haematologica
Published: December 18, 2025
Clinical strategies for leukemia management: Recommendations from the Bridging the Gaps in Hematology Oncology Consensus Conference 2025.
Journal: Leukemia research
Published: September 16, 2025
Factors affecting treatment decisions for lower-risk myelodysplastic syndromes across practice settings.
Journal: Leukemia & lymphoma
Published: August 25, 2025
ACR Appropriateness Criteria® Staging and Follow-Up of Leukemia.
Journal: Journal of the American College of Radiology : JACR
Published: August 22, 2025
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activation.
Journal: Cell reports
Published: June 02, 2025
VEXAS syndrome-associated tumefactive demyelination.
Journal: Journal of neurology
Published: April 30, 2025
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard.
Journal: EClinicalMedicine
Published: April 01, 2025
Risk prediction for clonal cytopenia: multicenter real-world evidence.
Journal: Blood
Published: March 22, 2024
Last Updated: 09/26/2026